arrow_back Back to App

Patients' Right to Know: New Prescription Drug Information Rules

This act aims to ensure that every patient receiving prescription medication gets a clear, understandable, and standardized paper information leaflet. This will better inform citizens about their medications, proper use, potential side effects, and interactions, thereby improving safety and reducing healthcare costs.
Key points
Mandatory, standardized paper leaflets with every prescription drug, containing key information.
Leaflets will include drug name, indications, proper use, side effects, interactions, and manufacturer contact.
Information will be in plain language with graphics for easy understanding by everyone.
The goal is to enhance patient safety and reduce adverse drug events.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6519
Sponsor: Rep. Golden, Jared F. [D-ME-2]
Process start date: 2022-01-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Patients’ Right to Know Their Medication Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6519.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-01-28.

What are the main provisions?

Key points include:

  • Mandatory, standardized paper leaflets with every prescription drug, containing key information.
  • Leaflets will include drug name, indications, proper use, side effects, interactions, and manufacturer contact.
  • Information will be in plain language with graphics for easy understanding by everyone.
  • The goal is to enhance patient safety and reduce adverse drug events.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Golden, Jared F. [D-ME-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health